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Abstract
Background: Colorectal cancer (CRC) is a leading cause of cancer death worldwide. Epidemiological risk factors for CRC
included alcohol intake, which is mainly metabolized to acetaldehyde by alcohol dehydrogenase and further oxidized to
acetate by aldehyde dehydrogenase; consequently, the role of genes in the alcohol metabolism pathways is of particular
interest. The aim of this study is to analyze the association between SNPs in ADH1B and ALDH2 genes and CRC risk, and also
the main effect of alcohol consumption on CRC risk in the study population.
Methodology/Principal Findings: SNPs from ADH1B and ALDH2 genes, included in alcohol metabolism pathway, were
genotyped in 1694 CRC cases and 1851 matched controls from the Molecular Epidemiology of Colorectal Cancer study.
Information on clinicopathological characteristics, lifestyle and dietary habits were also obtained. Logistic regression and
association analysis were conducted. A positive association between alcohol consumption and CRC risk was observed in
male participants from the Molecular Epidemiology of Colorectal Cancer study (MECC) study (OR = 1.47; 95%CI = 1.18-1.81).
Moreover, the SNPs rs1229984 in ADH1B gene was found to be associated with CRC risk: under the recessive model, the OR
was 1.75 for A/A genotype (95%CI = 1.21-2.52; p-value = 0.0025). A path analysis based on structural equation modeling
showed a direct effect of ADH1B gene polymorphisms on colorectal carcinogenesis and also an indirect effect mediated
through alcohol consumption.
Conclusions/Significance: Genetic polymorphisms in the alcohol metabolism pathways have a potential role in colorectal
carcinogenesis, probably due to the differences in the ethanol metabolism and acetaldehyde oxidation of these enzyme
variants.
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Introduction
Colorectal cancer (CRC) is a leading cause of death worldwide,
with over one million new cases and half a million deaths around
the world every year [1,2]. Risk factors for CRC include advanced
age, medical history of benign adenomatous polyps and inflam-
matory bowel diseases, family history of CRC, low intake of
vegetables and fruits and high intake of dietary fat (particularly
animal fat) and processed meat [3,4,5,6]. Chronic consumption of
non-steroidal anti-inflammatory drugs, hormone replacement
therapy and statins are protective [7,8]. The role of other lifestyle
factors such as tobacco smoking [9,10] or alcohol consumption
[11,12,13,14,15,16] remains inconclusive. Alcohol consumption
has been reported to be associated with modest increased risks of
CRC in some studies [17], but cancer risk may differ by tumor
molecular subtype and anatomical site.
Although the mechanism by which alcohol influences CRC risk
also remains not well understood [18], different hypothesis have
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been suggested: a carcinogenic effect of chemicals other than
ethanol present in alcoholic beverages such as nitrosamines, a
solvent action than facilitates absorption of other carcinogens, an
inhibition of methylation caused by ethanol, or a carcinogenic and
genotoxic role for acetaldehyde, the major metabolite of ethanol
[19,20]. There is sufficient evidence for the carcinogenicity of
ethanol in experimental animals, and it is also considered
carcinogenic to humans. Especially, there is evidence on the fact
that drinking of alcoholic beverages is causally related to cancers of
the oral cavity, pharynx, larynx and liver (IARC Group1);
However, there is controversial evidence on the effect of alcohol
consumption on gastric or colorectal cancer [21]. Moreover, there
is increasing evidence that acetaldehyde, a cytotoxic, mutagenic,
and carcinogenic metabolite of ethanol, is responsible for tumor
enhancing effects leading to aberrant cell proliferation. Acetalde-
hyde can also bind to DNA, leading to the formation of stable
DNA adducts and the generation of reactive oxygen species (ROS)
that may cause replication errors and mutations in oncogenes and
tumor suppressor genes [19,22,23,24,25]. Moreover, some studies
have reported epigenetic alterations by alcohol metabolites
including selective acetylation, methylation, and phosphorylation
of histones that regulate gene expression during disease patho-
genesis [26,27,28].
The amount of acetaldehyde present in various tissues following
ethanol ingestion may not only depend on the amount of ethanol
consumed but also on specific alleles of genes coding for ethanol-
metabolizing enzymes. Ethanol is metabolized to acetaldehyde
mainly by alcohol dehydrogenase (ADH) enzyme, and is further
oxidized to acetate by acetaldehyde dehydrogenase (ALDH)
(Supporting file Figure S1). Single nucleotide polymorphisms
(SNPs) of ADH1B and ALDH2, the genes that encodes the key
enzymes in alcohol metabolism, might cause variations in the
amount of production and/or oxidation of acetaldehyde between
individuals [18,19,29]. Therefore, polymorphisms in genes
involved in alcohol metabolism pathways might influence CRC
susceptibility.
The aim of the present study is to assess the association between
SNPs in alcohol metabolism genes, in particular in ADH1B and
ALDH2 genes, and CRC, and the main effect of alcohol
consumption on CRC risk in the study population. The analyses
have been performed within a large population-based case-control
study conducted in Israel, the Molecular Epidemiology of
Colorectal Cancer study (MECC) study.
Methods
Patients
The MECC study has already been described in detail [8,30].
In brief, it is a population based case-control study of incident,
pathologically confirmed, invasive CRC diagnosed between May
31, 1998 and March 31, 2004 and who lived in a geographically-
defined area of Northern Israel.
Controls with no prior history of CRC were identified from the
same source population using the Clalit Health Services (CHS)
database, covering ,70% of the older population. Controls were
matched to cases by year of birth, gender, primary clinic location,
and Jewish or Arab ethnicity. Participants provided written
informed consent at the time of enrollment. The Institutional
Review Boards at the Carmel Medical Center, the University of
Michigan, and the University of Southern California approved all
procedures. The study population included 2100 matched pairs.
For this analysis, 1780 cases and 1864 controls with available
DNA for genetic analysis will be used. The demographic
characteristics of the subjects not included do not differ from
those analyzed (data not shown).
Life-style information
Participants were interviewed face-to-face by trained monitors
with a comprehensive epidemiological questionnaire that assessed
demographic information, personal and family history of cancer,
reproductive history and medical history, medication use, health
habits and a food-frequency questionnaire.
Patient’s weight was recorded by self-report, as estimated one
year before diagnosis for cases and at the time of interview for
controls. Body mass index (BMI) was estimated one year before
the diagnosis from self-reported weight and height.
Comprehensive dietary habits were obtained with the use of a
validated food-frequency questionnaire modified for the Israeli
diet. Alcohol frequency was registered as the alcohol consumption
for the past five years before CRC diagnosis; beer, wine and other
hard liquor were recorded separately (the question was exactly
‘‘have you ever consumed beer and/or wine and/or other hard
liquor at least once a weak for at least one year?’’). Alcohol
consumption was converted to a categorical variable that includes
three levels of consumption: non-drinkers, occasional drinkers
(participants who only drink wine for the blessing) and drinkers.
The prevalence of alcohol consumption in the study population is
low, like in other Jewish population [31,32]. Total fat and
vegetable intakes were estimated from the questionnaire using
local food composition tables. Similar estimates provided total
energy consumption.
Physical activity was recorded for the longest occupation and
also recreational physical exercise. These were combined into an
ordinal index ranging from sedentary to intense physical activity.
SNP selection and genotyping
SNPs in two candidate genes related to key alcohol metabolism
pathways, specifically rs1229884 in ADH1B gene and rs886205 in
ALDH2, were selected for analysis within a larger exploratory
project including other hypothesis. The SNPs were selected as
maximally informative htSNPs when the regions were analyzed
with HaploTagger. SNPs were genotyped using Illumina Bead-
Station and BeadExpress platforms. Data were analyzed using
unsupervised Illumina BeadStation SNP calling automated rou-
tines, and the distribution of genotypes was compared to those
expected from Hardy-Weinberg equilibrium. Genotypes were also
confirmed with a second platform in at least 1% of samples.
Statistical Methods
Unconditional logistic regression was used to assess the
association between genotypes and CRC risk. All models included
age and gender to account for the matching design and avoid
excluding incomplete pairs due to DNA unavailability or missing
values in other variables. The total number of cases and controls
with both, lifestyle information and genetic data available for this
analysis were 1694 and 1851, respectively. Baseline characteristics
did not differ to the complete dataset. Analyses regarding alcohol
have been restricted to men due to the low prevalence of alcohol
consumption among the female population.
To estimate the magnitude of the associations, multivariate-
adjusted odds ratios (OR) and their corresponding 95% confi-
dence intervals (CI) were calculated for each genotype compared
to those homozygous for the common allele. Also a log-additive
model was fitted (trend test). Genetic analysis were performed with
the SNPstats web software [33] and SNPassoc library from R
package [34]. A panel of 300 anonymous SNPs useful for
population stratification analysis was analyzed in these subjects
ADH1B and ALDH2 Polymorphisms Colorectal Cancer
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in relation to other larger genotyping project. No relevant
population structure was identified that could not be explained
by reported ethnicity. Although the potential confounding of this
variable was rejected after a sensitivity analysis (data not shown) it
was also included in the models as a potential confounder.
A global 5% significance level was desired for the analyses of
SNPs. All reported p-values are two-tailed, and adjusted for age,
sex, ethnicity, energy intake and physical activity. Other variables
were assessed as potential confounders (i.e., BMI, vegetable
consumption, fat intake, red meat consumption) but were not
included in the modes since they did not significantly alter the
estimates (results not shown).
To simultaneously study the associations between SNPs,
potential confounding variables and CRC we also fitted structural
equation models (SEM) to assess the direct effect of genetic
polymorphisms on CRC (unexplained by candidate variables), and
also their indirect effect, mediated through lifestyle related factors,
by including all variables in the same model to assess overall
associations. These analyses were performed using the structural
equation modeling library from R package. SEM was used to test
the conceptual model since, in contrast to traditional analytical
procedures as linear regression analysis, SEM allows distinguishing
between direct and indirect effects and provides information on
the degree of fit for the entire model. In SEM the covariance
structure that follows from the proposed model is fitted to the
observed covariance. The maximum likelihood estimate method
yields estimates of the regression coefficients in the model,
standard errors and an overall goodness-of-fit test [35].
Results
The study population included 3545 participants, 1694 cases
and 1851 controls, with available data regarding epidemiological
interviews (including alcohol consumption) and genetic analysis. A
description of the subjects’ characteristics is in Table 1. Cases had
larger reported weight and BMI one year before the diagnosis than
controls. Cases also reported more family history of CRC and
lower physical activity and vegetable intake than controls, and
were more often Ashkenazi than Sephardi.
Though energy intake was similar for cases and controls, total
fat intake was larger for cases than controls. Long term regular use
of aspirin and statins were also inversely associated with CRC risk.
Smoking habits were similar in cases and controls, while higher
proportion of cases reported alcohol consumption for the five years
before diagnosis than controls (p,0.001).
A description of subjects’ characteristics by categories of alcohol
consumption is in Table 2. Only 17% of participants reported
alcohol consumption (other than wine for the blessing) for the past
five years. No differences were observed regarding reported BMI,
ethnicity, long term use of aspirin and statins and family history of
CRC. Alcohol drinkers were mainly men, Christian religion, and
had higher vegetables, fat and energy intakes. A large difference of
alcohol consumption prevalence was observed between men and
women. Since the prevalence of alcohol drinking in women was
very low (,5%), women were excluded from the association
analysis. Baseline characteristics of men’s population included in
the study is shown in Table 1, and also by alcohol consumption in
Table 2.
Alcohol consumption and CRC risk
Although the prevalence of alcohol consumption in the study
population was low, and only 29% of men reported alcohol
consumption (other than wine for the blessing) for five years
before CRC diagnostic, the prevalence of alcohol consumption
was higher in male cases than in male controls (p,0.01) (Table
1). The odds ratio (OR) adjusted for age, ethnicity, religion,
energy intake and physical activity was 1.47 (95%CI = 1.18-
1.81; p = 0.0004).
Alcohol metabolism SNPs and CRC risk
SNPs in 2 candidate genes related to key alcohol metabolism
pathways, specifically rs1229884 in ADH1B gene and rs886205
in ALDH2, were genotyped in CRC cases and controls and
selected for the present analysis. A detailed description of the
allele and genotype frequencies for the studied SNPs is shown
in Supporting Information file Table S1. Details of the
association between ADH1B and ALDH2 polymorphisms and
CRC risk are shown in Table 3. Except for those indicated,
ORs were adjusted for age, ethnicity, religion energy intake
and physical activity, and the association analysis was restricted
to men. The model of inheritance presented in tables was
selected on the basis of the lowest value of Akaike’s information
criterion.
An association was observed between rs1229984 polymorphism
in ADH1B and CRC risk. The A allele of this SNP was associated
with an increased risk of CRC. Under the recessive model, the
multi-adjusted OR was 1.75 for A/A genotype (95%CI= 1.21-
2.52, p-value = 0.0025).
No association between rs886205 polymorphism in ALDH2 and
CRC risk was observed. Under the dominant model, the OR
adjusted for potential confounders was 0.94 for T/C and C/C
genotypes (95%CI= 0.76-1.17, p-value = 0.57). No significant
interaction between ADH1B and ALDH2 polymorphisms was
observed (p= 0.89; data not shown).
Alcohol metabolism SNPs and alcohol consumption
The association between ADH1B and ALDH2 polymorphisms
and alcohol consumption in men controls is shown in Table 4. The
recessive model for polymorphism rs1229984 in ADH1B showed a
non-significant association with alcohol consumption (OR=1.79,
95%CI=0.97-3.28, p= 0.068). However, polymorphism
rs886205 in ALDH2 was not associated to alcohol consumption
(OR=1.06, 95%CI= 0.75-1.50, p = 0.75). No significant interac-
tions were observed between ADH1B polymorphisms and alcohol
consumption or between ALDH2 polymorphisms and alcohol
consumption (p = 0.73 and p= 0.81, respectively; data not shown).
Path analysis of SNPs, alcohol consumption, physical
activity, energy intake, ethnicity and CRC
The main aim of this analysis was to perform, beyond the
association study, a combined analysis of all players in alcohol
metabolism. Path analysis using structural equation models (SEM)
provide an interesting tool for this, since a simultaneous estimate of
associations can be done for an a priori proposed model. We built
the model from the observed associations in the multiple
univariate analyses previously described and tried to fit SEM to
identify strong association resistant to adjustment for indirect
effects.
Figure 1 shows the proposed model reduced to relevant
associations. The continuous arrows show the associations that
remain significant in the SEM. Discontinuous arrows show
associations that were no longer significant and could be
considered as indirect effects. This analysis confirms the direct
effect of ADH1B on CRC and also an indirect effect of such
polymorphisms through alcohol consumption. Behavioral vari-
ables, like energy intake and physical exercise, also remain related
among each other and associated to CRC.
ADH1B and ALDH2 Polymorphisms Colorectal Cancer
PLOS ONE | www.plosone.org 3 November 2013 | Volume 8 | Issue 11 | e80158
Discussion
We have examined the association between alcohol consump-
tion, polymorphisms in alcohol metabolism genes and the risk of
CRC. An increased risk of CRC was observed in alcohol drinkers.
Polymorphism rs1229984 in ADH1B has been found to be directly
associated with CRC risk and it also shows an indirect effect,
mediated through alcohol consumption, even when energy intake,
physical activity and religion are included in the model as potential
confounders. No association between ALDH2 polymorphism
rs886205 and CRC risk was observed, neither by the indirect
effect of such polymorphisms on alcohol consumption.
In humans, the major enzymes involved in the alcohol
metabolizing pathways are alcohol dehydrogenase-1B (ADH1B)
and aldehyde dehydrogenase-2 (ALDH2). ADH1B, that is ex-
pressed in the liver and present in gastrointestinal tract, metabolize
ethanol to acetaldehyde that is further oxidized to acetate by
ALDH2 [19]. The activity of these enzymes varies between
individuals, so genetic polymorphisms in ADH1B and ALDH2
genes could be responsible for differences in the expression and
activity of the enzymes as well as the subsequent metabolites
generated by the enzymes. Polymorphisms in genes responsible for
these pathways can affect the amount of acetaldehyde and reactive
oxygen species generated during the metabolic process, altering
Table 1 Baseline characteristics of cases and controls from the study population.
Clinical/Baseline characteristics All participants Men only
Controls Cases p-value Controls Cases p-value
N (%) 1864 (51) 1780 (49) 931 (51) 894 (49)
Age - mean (SD) 70.6 (11.7) 70.2 (11.7) 0.34 71.3 (11.3) 70.9 (11.3) 0.40
Sex 0.87
Male - N (%) 931 (50) 894 (50)
Female - N (%) 933 (50) 886 (50)
BMI - mean (SD) 26.9 (4.6) 27.3 (4.6) 0.027 26.4 (3.7) 27.1 (4.1) 0.00058
History of colorectal cancer in first-degree relative 0.0018 0.12
No - N (%) 1722 (93) 1571 (90) 866 (93) 806 (91)
Yes - N (%) 132 (7) 175 (10) 61 (7) 75 (9)
Physical activity ,0.0001 0.0011
Sedentary 1105 (62) 1231 (69) 516 (56) 571 (64)
Intermediate 447 (25) 311 (18) 226 (24) 173 (19)
Active 241 (13) 238 (13) 189 (20) 150 (17)
Ethnicity ,0.0001 0.0009
Ashkenazi 1176 (63) 1249 (70) 595 (64) 633 (71)
Sephardi 445 (24) 297 (17) 219 (23) 149 (17)
Other 241 (13) 234 (13) 117 (13) 112 (12)
Religion 0.33 0.94
Jew 1651 (89) 1576 (88.54) 828 (88.94) 796 (89.04)
Christian 91 (5) 102 (5.73) 49 (5.26) 49 (5.48)
Moslem 122 (6) 102 (5.73) 54 (5.8) 49 (5.48)
Vegetable intake (g/day) - mean (SD) 7.9 (3.7) 7.5 (4.5) 0.0061 8.1 (3.7) 7.6 (4.1) 0.0026
Regular aspirin intake
No - N (%) 1170 (63) 1192 (70) ,0.0001 524 (56) 558 (64) 0.0001
Yes - N (%) 692 (37) 531 (30) 406 (44) 317 (36)
Regular statin intake
No - N (%) 1623 (88) 1630 (94) ,0.0001 795 (86) 819 (93) ,0.0001
Yes - N (%) 228 (12) 101 (9) 128 (14) 59 (7)
Energy intake (Kcal/day) - mean (SD) 1856 (1114) 1889 (1587) 0.48 1996 ( 1249) 2058 (1878) 0.41
Total fat intake (g/day) - mean (SD) 66.1 (44.9) 69.3 (67.5) 0.0968 71.3 (50.4) 76.6 (81.8) 0.1016
Smoking
Never smoker- N (%) 1035 (56) 993 (57) 0.38 327 (35) 323 (37) 0.53
Ever smoker - N (%) 826 (44) 747 (43) 603 (65) 560 (63)
Alcohol consumption, past five years
No or occasionally- N (%) 1587 (85) 1405 (81) 0.0002 693 (75) 599 (68) 0.0013
Yes - N (%) 272 (15) 336 (19) 235 (25) 284 (32)
doi:10.1371/journal.pone.0080158.t001
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the effects of alcohol, and potentially leading to carcinogenesis
[36,37].
It has been reported that after alcohol absorption, the
concentration of alcohol in the colon is higher than in the
blood. In animal experiments, acetaldehyde concentration in
the mucosa of large intestine could exceed the concentration
that is considered to be mutagenic. Moreover, when
aldehyde dehydrogenase activity was inhibited, tumorigenesis
was observed in the colon of rats. In addition, bacteria in
the large intestine can also metabolize alcohol into
acetaldehyde, but do not metabolize acetaldehyde to acetic
acid for detoxification, so this cytotoxic metabolite could
accumulate and reach high concentrations in the colon
[19,38,39,40].
Previous studies have reported associations between polymor-
phisms of alcohol metabolizing enzymes and CRC risk, mainly in
oriental population, but results are inconclusive since associations
reported are not always replicated by other studies
[36,37,41,42,43,44,45]. The most frequently reported loci are
ADH1B Arg47His (rs1229984), because the activity of ADH1B
decreased by 40-fold in ADH1B His/His individuals, and ALDH2
Glu487Lys (rs671), which affects the Km of this enzyme for
alcohol with loss of the enzyme activity in individuals with the
ALDH2 Lys/Lys phenotype. However, most of these studies were
Table 2 Distribution of participant characteristics by categories of alcohol consumption.
Clinical/Baseline characteristics Alcohol consumption (all participants) Alcohol consumption (men only)
No or Occasional Yes p-value No or Occasional Yes p-value
N (%) 2992 (83) 608 (17) 1292 (71) 519 (29)
Age - mean (SD) 70.5 (11.7) 69.4 (11.3) 0.028 71.59 (11.37) 69.87 (11.10) 0.0032
Sex ,0.0001
Male - N (%) 1292 (43) 519 (85)
Female - N (%) 1700 (57) 89 (15)
BMI - mean (SD) 27.1 (4.8) 26.7 (3.7) 0.016 26.7 (4.1) 26.7 (3.5) 0.82
History of colorectal cancer in first-degree relative 0.96 0.45
No - N (%) 2707 (91) 552 (91) 1186 (93) 473 (92)
Yes - N (%) 253 (9) 52 (9) 93 (7) 43 (8)
Physical activity ,0.0001 ,0.0001
Sedentary 1990 (66) 307 (51) 815 (63) 261 (50)
Intermediate 593 (20) 141 (23) 274 (21) 124 (24)
Active 409 (14) 160 (26) 203 (16) 134 (26)
Ethnicity 0.25 0.14
Ashkenazi 1977 (66) 413 (68) 868 (67) 351 (68)
Sephardi 627 (21) 110 (18) 272 (21) 93 (18)
Other 388 (13) 85 (14) 152 (12) 75 (14)
Religion ,0.0001 ,0.0001
Jew 2647 (88) 538 (89) 1155 (89) 457 (88)
Christian 135 (5) 57 (9) 48 (4) 49 (9)
Moslem 210 (7) 13 (2) 89 (7) 13 (3)
Vegetable intake (g/day) - mean (SD) 7.5 (4.1) 8.5 (4.1) ,0.0001 7.6 (3.9) 8.4 (4.0) 0.0003
Regular aspirin intake
No - N (%) 1977 (66.2) 378 (62.3) 0.17 763 (59.3) 315 (60.8) 0.12
Yes - N (%) 994 (33.3) 225 (37.1) 522 (40.6) 199 (38.4)
Regular statin intake
No - N (%) 2700 (91) 540 (90) 0.25 1147 (90) 459 (89) 0.66
Yes - N (%) 265 (9) 63 (10) 130 (10) 56 (11)
Energy intake (Kcal/day) - mean (SD) 1811 (931) 2178 (1022) ,0.0001 1957 (1042) 2200 (1031) 0.0059
Total fat intake (g/day) - mean (SD) 65.1 (53.5) 80.9 (70.1) ,0.0001 70.8 (65.1) 81.8 (72.7) 0.0030
Smoking
Never smoker- N (%) 1853 (62) 170 (28) ,0.0001 528 (41) 120 (23) ,0.0001
Ever smoker - N (%) 1132 (38) 438 (72) 762 (59) 399 (77)
Participant status
Control- N (%) 1587 (53) 272 (45) 0.0002 693 (54) 235 (45) 0.0013
Case - N (%) 1405 (47) 336 (55) 599 (46) 284 (55)
doi:10.1371/journal.pone.0080158.t002
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focused on the functional loci reported in other diseases; only the
study of Yang et al, 2009 [36] reported a tagSNP-based
association study to investigate novel loci that have not been
reported before, including the ones analyzed in our study,
rs1229984 SNP of ADH1B gene and rs886205 of ALDH2 gene.
In this hospital-based case-control study of 440 CRC patients and
800 cancer-free controls in Southwestern Chinese population,
none of these 2 SNPs were significantly associated with CRC risk.
Recently, Ferrari et al. [44] evaluated the impact of rs1229984
polymorphisms and CRC risk in a nested case-control study (1269
cases and 2107 matched controls) within the European Prospective
Investigation into Cancer and Nutrition study (EPIC) and they
founded that the SNP was associated with a reduction in alcohol
consumption but not with CRC risk overall in Western-European
Populations.
Our results showed direct effect of ADH1B gene polymorphisms
on colorectal carcinogenesis and also a weak indirect effect of such
polymorphisms mediated through alcohol consumption, even
including energy intake and physical activity in the models as
potential confounders. Since polymorphisms in ADH1B gene
contributed in the increased risk of CRC, the role of this enzyme
in colorectal carcinogenesis could be due to its efficiency in ethanol
metabolization and acetaldehyde detoxification and to the amount
of acetaldehyde that is consequently accumulated leading to
colorectal carcinogenesis.
This study is one of the largest conducted so far in which
polymorphisms in alcohol metabolism genes have been studied in
the global context of energy intake and physical activity in relation
to CRC. The population-based case-control design, though
retrospective, has revealed useful to identify a series of associations
that allow a global picture of the key players. Some of the reported
associations had been previously reported in studies of specific
factors, which reinforces the strength of the proposed model. The
path analysis using structural equations models, though not novel,
is a good tool to provide a comprehensive analysis of all the players
in the putative causal model. This analysis has identified direct and
mediated effects of alcohol-related factors and CRC risk. The
study also has some limitations. Most important ones are that
alcohol intake was assessed only by self-report questionnaire,
which may be liable to reporting biases. The population under
study is characterized by a low prevalence of alcohol consumption,
mostly related to religious traditions among Jewish and Arabs.
This has impacted in a reduced sample size in the alcohol-exposed
categories. Also, the polymorphisms studied have been reduced to
one SNP per gene, which may not be enough to capture all the
genetic variability.
Conclusion
Our results suggest a role of polymorphism rs1229984 in
ADH1B in colorectal carcinogenesis but have failed to show such
association for polymorphism rs886205 in ALDH2. Although our
findings require validation in other independent population,
further characterization of ADH1B and ALDH2 polymorphisms
may provide new insights into their contribution to incidence and
progression of CRC.
Table 3 Association between polymorphisms in alcohol
metabolism genes and colorectal cancer risk (men only).
SNP Controls Cases OR1 95% CI p-value
N (%) N (%)
ADH1B
rs1229984
927 (51.9) 860 (48.1) 0.0096
G/G 513 (55.3) 457 (53.1) 1.00
G/A 360 (38.8) 324 (37.7) 1.04 (0.85–1.26)
A/A 54 (5.8) 79 (9.2) 1.77 (1.22–2.58)
Recessive (A/A) 54 (5.8) 79 (9.2) 1.75 (1.21–2.52) 0.0025
ALDH2
rs886205
916 (51.8) 854 (48.2) 0.61
T/T 658 (71.8) 637 (74.6) 1.00
T/C 228 (24.9) 189 (22.1) 0.91 (0.73–1.15)
C/C 30 (3.3) 28 (3.3) 1.16 (0.67–1.99)
Dominant
(T/C-C/C)
258 (28.2) 217 (25.4) 0.94 (0.76–1.17) 0.57
1OR adjusted for age, ethnicity, religion, energy intake and physical activity.
doi:10.1371/journal.pone.0080158.t003
Table 4 Association between polymorphisms in alcohol metabolism genes and alcohol consumption (men only).
SNP Alcohol consumption OR1 95% CI p-value
No or Occasional Yes
N (%) N (%)
ADH1B rs1229984 690 (74.7) 234 (25.3) 0.10
G/G 378 (54.8) 133 (56.8) 1.00
G/A 276 (40.0) 83 (35.5) 0.83 (0.60–1.15)
A/A 36 (5.2) 18 (7.7) 1.66 (0.89–3.08)
Recessive (A/A) 36 (5.2) 18 (7.7) 1.79 (0.97–3.28) 0.068
ALDH2 rs886205 682 (74.7) 231 (25.3) 0.69
T/T 493 (72.3) 164 (71.0) 1.00
T/C 166 (24.3) 62 (26.8) 1.10 (0.77–1.57)
C/C 23 (3.4) 5 (2.2) 0.72 (0.25–2.02)
Dominant (T/C-C/C) 189 (27.7) 67 (29.0) 1.06 (0.75–1.50) 0.75
1OR adjusted for age, ethnicity, religion, energy intake and physical activity.
doi:10.1371/journal.pone.0080158.t004
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